Mallinckrodt Pharmaceuticals

Write a Review301-961-3400

Founded in 1996, Sucampo Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of medicines based on prostones. It develops prostones for the treatment of gastrointestinal, respiratory, vascular and central nervous system diseases and disorders. The company markets AMITIZA in the United States for chronic idiopathic constipation problems in adults. Sucampo Pharmaceuticals operates Sucampo Pharma Europe and Sucampo Pharma subsidiaries. In addition, it offers research and development services and conducts clinical trials. The company also has a sales force that focuses on the institutional and long-term care markets. Sucampo Pharmaceuticals additionally develops and commercializes prostone-based compounds.